CAD & Atherosclerosis
Conference Coverage
Majority of muscle symptoms with statins not caused by treatment
A new Cholesterol Trialists Collaboration meta-analysis shows that in 14 of the 15 people who experience muscle pain or weakness when taking a...
Conference Coverage
Evolocumab benefits accrue with longer follow-up: FOURIER OLE
Chief among the benefits was a reduction in cardiovascular mortality not observed in the pivotal trial that led to U.S. approval of evolocumab.
Guidelines
ACC fills gaps on guidance for nonstatin therapies for LDL-C lowering
The new guidance addresses the role of nonstatin therapies for lowering LDL-C, which were not addressed in the 2018 ACC/AHA guideline on...
Conference Coverage
No benefit of routine stress test POST-PCI in high-risk patients
Routine functional testing provided no advantage on clinical outcomes over standard care among high-risk patients after intervention, suggesting ‘...
Conference Coverage
AXIOMATIC-SSP: Cautious optimism on factor XI inhibitor in stroke
The new factor XI inhibitor antithrombotic, milvexian, showed promising results in a dose-finding phase 2 trial in patients with acute ischemic...
Conference Coverage
ALL-HEART: No benefit of allopurinol in ischemic heart disease
Allopurinol failed to affect a composite of nonfatal MI, nonfatal stroke, or CV death, in a randomized trial that was ‘definitively neutral’ in...
Conference Coverage
Artificial intelligence poised to change paradigm of CV risk prevention
A new generation causal-based AI algorithm promises to personalize CV risk management to prevent events.
Conference Coverage
DANCAVAS misses primary endpoint but hints at benefit from comprehensive CV screening
Comprehensive cardiovascular screening fell short of significantly reducing all-cause mortality in men aged 65-74, but some benefits were seen.
Feature
High-dose loop diuretic can raise post–cardiac surgery mortality
Furosemide at high doses after cardiac surgeries like valve replacement or coronary bypass can prolong ICU stays and worsen mortality, a cohort...
From the Journals
Multibiomarker risk score predicts complex revascularization
The findings provide insight into the relationship between cardiovascular biomarkers, coronary anatomical complexity, and incident clinical events...
Conference Coverage
Secondary CV prevention benefit from polypill promises global health benefit
In older patients with a prior myocardial infarction, a three-drug polypill significantly reduced risk of CV events in the multinational SECURE...